ClinicalTrials.gg
Not yet recruitingNCT07734831TELEREHAB-BRUpdated Jul 29, 2026

TELEREHAB-BR: Cardiovascular Rehabilitation Models Trial

An interventional study of Hybrid Cardiac Telerehabilitation and Traditional Center-Based Cardiac Rehabilitation (TCR) in Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD)), Chronic Heart Failure and Acute Coronary Syndromes (ACS), sponsored by University of the State of Santa Catarina. Not yet recruiting at 1 site in Brazil. Open to participants aged 35 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-07-29.

Sponsored by University of the State of Santa Catarina · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
219
Allocation
Randomized
Ages
35 Years to 80 Years
Sex
All
01

Study summary

Introduction:

Cardiovascular diseases remain the leading cause of mortality worldwide. Despite the proven effectiveness of cardiac rehabilitation (CR) programs, adherence remains unsatisfactory, especially in public healthcare systems such as the Brazilian Unified Health System (Sistema Único de Saúde - SUS), due to logistical, geographical, and socioeconomic barriers. In this context, cardiac telerehabilitation (CTR) has emerged as a promising alternative, with effectiveness comparable to traditional center-based cardiac rehabilitation.

However, evidence regarding hybrid cardiac telerehabilitation models applicable to the Brazilian context, using simple and low-cost technologies, remains scarce.

Objectives:

To investigate adherence and its effects on the effectiveness, safety, and maintenance of exercise practice across different models of cardiac rehabilitation, with emphasis on the development and implementation of a hybrid cardiac telerehabilitation (HCTR) model adapted to the Brazilian context.

The primary outcome will be adherence to the exercise program, defined as participation in at least 75% of the proposed sessions during the 12-week intervention.

Secondary outcomes will include estimated cardiorespiratory fitness, functional capacity, functional mobility, handgrip strength, and health-related quality of life.

Adverse events, digital health literacy, exercise maintenance, hospitalizations, and benefits and barriers to exercise will be evaluated as exploratory variables.

Methods:

This is a pragmatic, single-center, three-arm parallel randomized clinical trial consisting of hybrid cardiac telerehabilitation (HCTR), traditional center-based cardiac rehabilitation (TCR), and a usual care (UC) group.

A total of 219 participants with coronary artery disease, with or without acute coronary syndrome, and/or stable heart failure, who are eligible for Phase II cardiac rehabilitation and receiving care through the Brazilian Unified Health System (Sistema Único de Saúde - SUS), will be enrolled.All participants will undergo standardized clinical and functional assessments at baseline, post-intervention, and short-term follow-up.

Clinical screening and exercise stress testing will be performed at the Santa Catarina Institute of Cardiology (Instituto de Cardiologia de Santa Catarina - ICSC), whereas physical assessments and interventions will be conducted at the Center for Cardio-Oncology and Exercise Medicine (Núcleo de Cardio-Oncologia e Medicina do Exercício - NCME), State University of Santa Catarina (UDESC).

The intervention will last 12 weeks, followed by an additional 12-week short-term follow-up period.

Participants allocated to the HCTR group will receive a hybrid intervention consisting of face-to-face sessions, synchronous sessions supervised through videoconferencing, and remotely monitored asynchronous activities.

Participants in the TCR group will participate exclusively in supervised face-to-face sessions, whereas participants in the UC group will receive usual clinical care, including conventional clinical guidance and an educational booklet.

Study Significance:

This clinical trial aims to generate evidence regarding adherence, effectiveness, safety, and maintenance of exercise practice across different models of cardiac rehabilitation. Furthermore, it seeks to provide evidence to support the development and implementation of a hybrid cardiac telerehabilitation model adapted to the Brazilian context and the Brazilian Unified Health System (SUS), contributing to expanding access to cardiac rehabilitation through accessible digital technologies.

02

Conditions studied

  • Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD))
  • Chronic Heart Failure
  • Acute Coronary Syndromes (ACS)

Keywords

  • Coronary Artery Disease
  • Heart Failure
  • Cardiac Rehabilitation
  • Telerehabilitation
  • Exercise Therapy
  • Health Literacy
  • Exercise Adherence
03

In context

Coronary Artery Disease

4,857 studies on the registry are indexed under Coronary Artery Disease; 890 are open to participants now.

This study's planned enrollment of 219 is above the median of 124 across 3,006 interventional studies indexed under Coronary Artery Disease.

Browse Coronary Artery Disease studies →

Lead sponsor

University of the State of Santa Catarina is the lead sponsor of 25 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
35 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosis of coronary artery disease (CAD), including patients with or without acute coronary syndrome (ACS), with or without ST-segment elevation, who were hospitalized for clinical management, percutaneous coronary intervention (PCI), or coronary artery bypass grafting (CABG).
  • Patients with heart failure and (LVEF) >20%. (NYHA) functional class I-III.
  • Clinically stable patients without limiting angina.
  • Patients who meet the study eligibility criteria and provide to participate.

Exclusion criteria

Exclusion Criteria:

  • Decompensated severe heart failure.
  • Unstable angina.
  • Atrial fibrillation with rapid ventricular response.
  • Myocarditis, recent embolism, or thrombophlebitis.
  • Disabling musculoskeletal disorders that preclude participation in the exercise program.
  • History of cardiac arrest with disabling neurological sequelae.
  • Any decompensated medical condition that precludes participation in the study.
  • More than 2 months since hospital discharge before screening.
  • No access to the internet via smartphone or computer.
  • Unable to access or use the online intervention platform.
  • Absence of a caregiver or companion available at home during participation in the study.
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

LVEF (left ventricular ejection fraction)

The share of blood the heart’s main pumping chamber (the left ventricle) pushes out with each beat, measured by an echocardiogram (heart ultrasound) or a MUGA scan. About 50–70% is normal.

NYHA class (heart failure)

The New York Heart Association’s four classes of how much heart failure limits physical activity.

I
No limits: ordinary activity causes no undue tiredness or breathlessness.
II
Slight limits: comfortable at rest, ordinary activity causes symptoms.
III
Marked limits: comfortable at rest, less than ordinary activity causes symptoms.
IV
Symptoms even at rest; any activity makes them worse.

Studies set their own limit — many outside heart failure leave out class III–IV, while heart failure studies may ask for a particular class. Check the class this study names.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
219 participants (estimated)

Study arms

  • Experimental
    Hybrid Cardiac Telerehabilitation (HCTR)

    Participants assigned to this arm will undergo a 12-week hybrid cardiac telerehabilitation program consisting of in-person sessions, synchronous activities supervised by videoconference, and asynchronous activities remotely monitored, according to the structured exercise protocol developed for this study.

    Behavioral: Hybrid Cardiac Telerehabilitation

  • Active comparator
    Traditional Center-Based Cardiac Rehabilitation

    Participants assigned to this arm will undergo a 12-week supervised traditional center-based cardiac rehabilitation program at the Center for Cardiology and Exercise Medicine (NCME/UDESC), according to institutional organization and service availability, following the structured exercise protocol developed for this study.

    Behavioral: Traditional Center-Based Cardiac Rehabilitation (TCR)

  • Active comparator
    Usual Care Group

    Participants assigned to this arm will remain under usual clinical care for 12 weeks, receiving standard clinical guidance and an educational booklet on the safe practice of physical exercise developed specifically for this study. The educational booklet is intended to standardize the guidance provided to participants, promote the safe practice of physical exercise, and ensure a minimum level of care throughout the study period. If clinically indicated, participants may be referred to the center-based cardiac rehabilitation program during or after the study period, subject to service availability and the participant's willingness to participate.

    Behavioral: Usual Care Group

Interventions

  • BehavioralHybrid Cardiac Telerehabilitation

    A 12-week hybrid cardiac telerehabilitation program consisting of three supervised group exercise sessions per week delivered through a hybrid model that combines in-person activities, synchronous exercise sessions via videoconference, and remotely monitored asynchronous activities. Exercise intensity will be individually prescribed based on the results of the baseline exercise stress test. The structured exercise program includes mobility and stretching exercises, light-to-moderate intensity aerobic exercise, and resistance exercises performed using elastic resistance bands. During the synchronous sessions, aerobic exercise will consist of rhythmic activities adapted for the home environment, including stationary marching, light displacement activities, alternating upper- and lower-limb movements, and low-impact functional exercises. During the asynchronous phase, participants will perform guided walking sessions and activities previously provided through instructional videos and educ

  • BehavioralTraditional Center-Based Cardiac Rehabilitation (TCR)

    A 12-week supervised traditional center-based cardiac rehabilitation program consisting of three supervised group exercise sessions per week. Exercise intensity will be individually prescribed based on the results of the baseline exercise stress test. The structured exercise program includes mobility and stretching exercises, aerobic exercise performed primarily on a treadmill or other equipment available at the cardiac rehabilitation center, and resistance exercises performed using elastic resistance bands. The intervention was designed to improve health-related physical fitness, functional capacity, quality of life, and adherence to regular physical exercise in patients eligible for Phase II cardiac rehabilitation.

  • BehavioralUsual Care Group

    Participants will remain under usual clinical care and will receive standard clinical guidance together with an educational booklet on the safe practice of physical exercise and cardiovascular health care.

06

What researchers measure

Primary outcomes

  1. Adherence to the Exercise Program

    Adherence to the exercise program will be defined as attendance at ≥75% of the prescribed supervised exercise sessions during the 12-week intervention. Adherence will be assessed using attendance records for in-person and synchronous sessions and digital participation records for asynchronous activities, according to the allocated intervention group.

    Time frame: During the 12-week intervention period

Secondary outcomes

  1. Peak Metabolic Equivalents (METs)

    Peak exercise capacity will be assessed using the Exercise Stress Test and expressed as the maximum metabolic equivalents (METs) achieved during the test.

    Time frame: Baseline, 12 weeks (T1), and 24 weeks (T2)

  2. Estimated Peak Oxygen Uptake (VO₂)

    Cardiorespiratory fitness will be assessed using the Exercise Stress Test and expressed as estimated peak oxygen uptake (VO₂), calculated using standardized prediction equations.

    Time frame: Baseline, 12 weeks (T1), and 24 weeks (T2)

  3. Exercise Test Duration

    Exercise capacity will be assessed using the Exercise Stress Test and expressed as the total exercise duration completed during the test.

    Time frame: Baseline, 12 weeks (T1), and 24 weeks (T2)

  4. Functional Capacity

    Functional capacity will be assessed using the 1-minute Sit-to-Stand Test, expressed as the total number of repetitions completed within one minute.

    Time frame: Baseline, 12 weeks (T1), and 24 weeks (T2)

  5. Functional Mobility

    Functional mobility will be assessed using the Timed Up and Go (TUG) test, expressed as the time required to complete the test in seconds.

    Time frame: Baseline, 12 weeks (T1), and 24 weeks (T2)

  6. Handgrip Strength

    Muscle strength will be assessed by handgrip strength using a Jamar hydraulic dynamometer, expressed in kilograms-force (kgf).

    Time frame: Baseline, 12 weeks (T1), and 24 weeks (T2)

  7. Health-Related Quality of Life

    Health-related quality of life will be assessed using the EuroQol Five-Dimension Five-Level questionnaire (EQ-5D-5L). The instrument includes a descriptive system comprising five dimensions (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression), each with five response levels ranging from no problems to extreme problems/unable to perform the activity. Responses define a health profile and are not summed into a total score. The questionnaire also includes the EuroQol Visual Analogue Scale (EQ VAS), which ranges from 0 (worst health imaginable) to 100 (best health imaginable). Higher EQ VAS scores indicate better perceived health status.

    Time frame: Baseline, 12 weeks (T1), and 24 weeks (T2)

Other outcomes

  1. Adverse Events

    Adverse events will be assessed through systematic recording of signs, symptoms, or clinical events occurring during supervised, synchronous, and remotely monitored exercise sessions throughout the study period.

    Time frame: During the 12-week intervention period

  2. Digital Health Literacy Assessed by the Brazilian eHealth Literacy Scale

    Digital health literacy will be assessed using the Brazilian version of the eHealth Literacy Scale (eHEALS-Br), an 8-item instrument with responses rated on a 5-point Likert scale, from 1 (strongly disagree) to 5 (strongly agree). Total scores range from 8 to 40, with higher scores indicating greater perceived digital health literacy. The total score will be analyzed as a potential explanatory variable associated with adherence and clinical outcomes.

    Time frame: Baseline, 12 weeks (T1), and 24 weeks (T2).

  3. Benefits and Barriers to Exercise

    Benefits and barriers to exercise will be assessed using the Exercise Benefits/Barriers Scale (EBBS), a 43-item questionnaire with responses rated on a 4-point Likert scale. Total scores range from 43 to 172, with higher total scores indicating a more positive perception of exercise (greater perceived benefits relative to perceived barriers). The total EBBS score will be analyzed as a potential explanatory factor associated with adherence and exercise maintenance.

    Time frame: Baseline, 12 weeks, and 24 weeks

  4. Exercise Maintenance

    Exercise maintenance will be assessed using a standardized follow-up questionnaire to evaluate the continuation of regular physical exercise after completion of the supervised intervention.

    Time frame: 24 weeks (end of follow-up)

  5. Hospitalizations

    Hospitalizations occurring from study enrollment until the end of the follow-up period will be assessed using a structured questionnaire and participant self-report.

    Time frame: 24 weeks (end of follow-up)

07

Study locations

1 site
  • Centro de Ciências da Saúde e do Esporte (CEFID/UDESC)
    Florianópolis, Santa Catarina 88080-350, Brazil
08

References and documents

Publications

  • Herdy AH, Mangia AS, Benetti M. Cardiovascular Telerehabilitation: An Alternative for Greater Availability of Cardiovascular and Metabolic Rehabilitation in Brazil. Arq Bras Cardiol. 2025 Mar;122(3):e20240570. doi: 10.36660/abc.20240570. English, Portuguese. PubMed 40197876 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 29, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07734831
Lead sponsor
University of the State of Santa Catarina
Collaborators
Instituto de Cardiologia de Santa Catarina
Responsible party
Ariella Sebastião Mangia (Principal Investigator, PhD Candidate, Graduate Program in Human Movement Sciences, Santa Catarina State University, University of the State of Santa Catarina) — Principal investigator
First posted
Jul 29, 2026
Start date
Aug 3, 2026 (estimated)
Primary completion
Aug 2027 (estimated)
Completion
Jul 2028 (estimated)
Last update
Jul 29, 2026

Study contacts

Ariella S Mangia, MSc, PhD(c)
Contact
ariella.mangia@edu.udesc.br
55- 48- 3664-8643 ext. 48- 988714049
Magnus Benetti, PhD
study chair · University of the State of Santa Catarina
Ariella S Mangia, MSc, PhD(c)
principal investigator · University of the State of Santa Catarina
Artur H Herdy, PhD
study chair · Instituto de Cardiologia de Santa Catarina
Gilvan M Pinto
study chair · Instituto de Cardiologia de Santa Catarina
Cícero A de Souza, PHD
study chair · Instituto de Cardiologia de Santa Catarina
Silvana M. de S. Pereira
study chair · Instituto de Cardiologia de Santa Catarina

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion